sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
×Ô¾õÐÔ¶¯ÂöÖàÑùÓ²»¯¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÐÄѪ¹Üϵͳģ×Ó > ×Ô¾õÐÔ¶¯ÂöÖàÑùÓ²»¯¶¯ÎïÄ£×Ó

ǰÑÔ

¶¯ÂöÖàÑùÓ²»¯(atherosclerosis)ÊÇCVD×î³£¼ûºÍ×î»ù±¾µÄ²¡Àí»ù´¡¡£¶¯ÂöÖàÑùÓ²»¯µÄÖ÷Òª²¡ÀíÀú³Ì°üÀ¨Ñª¹ÜÄÚÆ¤Ï¸°ûµÄ»î»¯¡¢µ¥ºËϸ°û𤸽²¢Ç¨áãµ½ÄÚĤÏ¡¢¾ÞÊÉϸ°ûÍÌÊÉÑõ»¯ÐÞÊεÄÖ¬ÂѰ×ת»¯ÎªÅÝĭϸ°û¡¢ÄÚĤÖÐĤÔöÉú£¬×îÖÕÐγÉÖàÑù°ß¿é»òÒýÆðѪ˨¹£ÈûѪ¹Ü£¬ÒýÆðȱѪÐÔ¼²²¡¡£ºã¾ÃÒÔÀ´£¬ һϵÁеÄʵÑ鶯ÎÈçСÊó¡¢´óÊó¡¢¼ÒÍᢵØÊ󡢺×ðÈ¡¢ÖíºÍºï×ӵȣ¬±»Ó¦ÓÃÓÚ¶¯ÂöÖàÑùÓ²»¯µÄÑо¿¡£

 

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î¶É±ßÍÃ(Watanabe heritable hyperlipidemic,WHHL£©

¡¾ÔìÄ£»úÖÆ¡¿£º

WHHL¼ÒÍÃÊǵ¥»ùÒòÒþÐÔÍ»±äÔì³ÉLDLrȱÏÝ£¬Í¨Ë×Òûʳ¾Í¿É·ºÆð¸ßµ¨¹Ì´¼ÑªÖ¢ºÍ¶¯ÂöÖàÑùÓ²»¯£¬ÆäÁÙ´²ÌØÕ÷ºÍ²¡Àíת±äÓëÈ˼Ò×åÐԸߵ¨¹Ì´¼ÑªÖ¢ºÜÊÇÏàËÆ¡£

¡¾Ä£×ÓÌØµã¡¿£º

WHHL¼ÒÍõÄѪÇ嵨¹Ì´¼Å¨¶ÈÊÇÕý³£ÈÕ±¾´ó¶ú°×ÍõÄ8~14±¶¡£Õý³£ÒûʳÏ£¬WHHL¼ÒÍÿÉÓÃÓÚÑо¿Ö¬ÂѰ׹¦Ð§¡¢¸ßµ¨¹Ì´¼ÑªÖ¢ºÍ¶¯ÂöÖàÑùÓ²»¯¡£1992Ä꣬¾ßÓйÚ×´¶¯ÂöÖàÑùÓ²»¯ÇãÏòµÄWHHL¼ÒÍÃÅàÓýÀֳɣ¬ÆäµÍÃܶÈÖ¬ÂѰ׵¨¹Ì´¼Ë®Æ½¸ßÇÒ¾ßÓе䷶µÄÓëÈËÏàËÆµÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯°ß¿é¡£¿ÉÊÇ£¬¸ÃÆ·ÖÖWHHL¼ÒÍÃ×Ô¾õÐÔÐ£ËÀµÄ±¬·¢ÂʺܵÍ¡£Ëæºó£¬Í¨¹ý½«ÓйÚ×´¶¯ÂöÖàÑùÓ²»¯ÇãÏòµÄWHHL¼ÒÍþÙÐÐÒ»Á¬Ñ¡ÔñÓýÖÖ£¬ÀÖ³ÉÅàÓý³öÓÐÐ£ËÀÇãÏòµÄWHHL¼ÒÍ㬸ÃÄ£×ÓΪÑо¿Ð£ËÀÌṩÁËÓÐÀûµÄ¹¤¾ß¡£

¡¾Ä£×ÓȪԴ¡¿£º

 WHHL¼ÒÍÃÔÚÈÕ±¾Éñ»§´óѧ´óѧԺҽѧÑо¿¿ÆÁ¥ÊôʵÑ鶯ÎïÉèÊ©(http://www.med.kobe-u.ac.jp/iea)±£ÖÖ¡¢·±Óý¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

ËäÈ»WHHL¼ÒÍÿÉÐγɶ¯ÂöÖàÑùÓ²»¯µÄÍíÆÚ²¡±ä£¬µ«È˹¤ÅàÓýµÄ×ÔȻȱÏݶ¯ÎïÄ£×Ó»ùÒòȱÏݼòµ¥£¬Æ·ÖÖ½ÏÉÙ£¬ÇÒ¼ÒÍò»Ò×»ñµÃ¡£

 

²Î¿¼ÎÄÏ×£º

1.Áõ¶÷᪣¬·¶½­ÁØ.ת»ùÒòÍÃÔÚ¶¯ÂöÖàÑùÓ²»¯Ñо¿ÖеÄÓ¦Óü°Ï£Íû£®Öйú¶¯ÂöÓ²»¯ÔÓÖ¾£¬2003£¬11(4):371-375

2.Fan J,Watanabe T.Transgenic rabbits as therapeutic protein bioreactors and human disease models. Pharmacol Ther, 2003, 99 (3): 261-282

3.Ishibashi S,Brown MS,Goldslein JL,el al. Hyperchol eslerolemia in low density lipoprolein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clio Invest, 1993, 92(2):883-893

4.Kita T, Brown MS, Watanabe Y, el al. Deficiency of low density lipoprotein receptors in li.ver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholeslerolem.ia. Proc Natl Acad Sci USA, 1981, 78 (4):2268-2272

5.Paigen B, Morrow A, Brandon C, el al. Variation in susceptibility lo atherosclerosis among inbred strains of mice. Atherosclerosis, 1985,57 (1):65-73

6.Piedrahita JA,Zhang SH,Hagaman JR,el al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA, 1992,89 (10):4471-4475

7.Plump AS,Smith JD, Hayek T, el al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-de[icient mice created by homologous recombination in ES cells. Cell, 1992, 71 (2):343-353

8.Yu Q,Li Y,WaqarAB,et al. Temporal and quantitative analysis of atherosclerotic lesions in diet-induced hypercholeslerolemic rabbits. J Biomed Biotechnol, 2012, 2012:506159

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÐÄѪ¹Üϵͳģ×Ó > ×Ô¾õÐÔ¶¯ÂöÖàÑùÓ²»¯¶¯ÎïÄ£×Ó
×Ô¾õÐÔ¶¯ÂöÖàÑùÓ²»¯¶¯ÎïÄ£×Ó

ǰÑÔ

¶¯ÂöÖàÑùÓ²»¯(atherosclerosis)ÊÇCVD×î³£¼ûºÍ×î»ù±¾µÄ²¡Àí»ù´¡¡£¶¯ÂöÖàÑùÓ²»¯µÄÖ÷Òª²¡ÀíÀú³Ì°üÀ¨Ñª¹ÜÄÚÆ¤Ï¸°ûµÄ»î»¯¡¢µ¥ºËϸ°û𤸽²¢Ç¨áãµ½ÄÚĤÏ¡¢¾ÞÊÉϸ°ûÍÌÊÉÑõ»¯ÐÞÊεÄÖ¬ÂѰ×ת»¯ÎªÅÝĭϸ°û¡¢ÄÚĤÖÐĤÔöÉú£¬×îÖÕÐγÉÖàÑù°ß¿é»òÒýÆðѪ˨¹£ÈûѪ¹Ü£¬ÒýÆðȱѪÐÔ¼²²¡¡£ºã¾ÃÒÔÀ´£¬ һϵÁеÄʵÑ鶯ÎÈçСÊó¡¢´óÊó¡¢¼ÒÍᢵØÊ󡢺×ðÈ¡¢ÖíºÍºï×ӵȣ¬±»Ó¦ÓÃÓÚ¶¯ÂöÖàÑùÓ²»¯µÄÑо¿¡£

 

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î¶É±ßÍÃ(Watanabe heritable hyperlipidemic,WHHL£©

¡¾ÔìÄ£»úÖÆ¡¿£º

WHHL¼ÒÍÃÊǵ¥»ùÒòÒþÐÔÍ»±äÔì³ÉLDLrȱÏÝ£¬Í¨Ë×Òûʳ¾Í¿É·ºÆð¸ßµ¨¹Ì´¼ÑªÖ¢ºÍ¶¯ÂöÖàÑùÓ²»¯£¬ÆäÁÙ´²ÌØÕ÷ºÍ²¡Àíת±äÓëÈ˼Ò×åÐԸߵ¨¹Ì´¼ÑªÖ¢ºÜÊÇÏàËÆ¡£

¡¾Ä£×ÓÌØµã¡¿£º

WHHL¼ÒÍõÄѪÇ嵨¹Ì´¼Å¨¶ÈÊÇÕý³£ÈÕ±¾´ó¶ú°×ÍõÄ8~14±¶¡£Õý³£ÒûʳÏ£¬WHHL¼ÒÍÿÉÓÃÓÚÑо¿Ö¬ÂѰ׹¦Ð§¡¢¸ßµ¨¹Ì´¼ÑªÖ¢ºÍ¶¯ÂöÖàÑùÓ²»¯¡£1992Ä꣬¾ßÓйÚ×´¶¯ÂöÖàÑùÓ²»¯ÇãÏòµÄWHHL¼ÒÍÃÅàÓýÀֳɣ¬ÆäµÍÃܶÈÖ¬ÂѰ׵¨¹Ì´¼Ë®Æ½¸ßÇÒ¾ßÓе䷶µÄÓëÈËÏàËÆµÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯°ß¿é¡£¿ÉÊÇ£¬¸ÃÆ·ÖÖWHHL¼ÒÍÃ×Ô¾õÐÔÐ£ËÀµÄ±¬·¢ÂʺܵÍ¡£Ëæºó£¬Í¨¹ý½«ÓйÚ×´¶¯ÂöÖàÑùÓ²»¯ÇãÏòµÄWHHL¼ÒÍþÙÐÐÒ»Á¬Ñ¡ÔñÓýÖÖ£¬ÀÖ³ÉÅàÓý³öÓÐÐ£ËÀÇãÏòµÄWHHL¼ÒÍ㬸ÃÄ£×ÓΪÑо¿Ð£ËÀÌṩÁËÓÐÀûµÄ¹¤¾ß¡£

¡¾Ä£×ÓȪԴ¡¿£º

 WHHL¼ÒÍÃÔÚÈÕ±¾Éñ»§´óѧ´óѧԺҽѧÑо¿¿ÆÁ¥ÊôʵÑ鶯ÎïÉèÊ©(http://www.med.kobe-u.ac.jp/iea)±£ÖÖ¡¢·±Óý¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

ËäÈ»WHHL¼ÒÍÿÉÐγɶ¯ÂöÖàÑùÓ²»¯µÄÍíÆÚ²¡±ä£¬µ«È˹¤ÅàÓýµÄ×ÔȻȱÏݶ¯ÎïÄ£×Ó»ùÒòȱÏݼòµ¥£¬Æ·ÖÖ½ÏÉÙ£¬ÇÒ¼ÒÍò»Ò×»ñµÃ¡£

 

²Î¿¼ÎÄÏ×£º

1.Áõ¶÷᪣¬·¶½­ÁØ.ת»ùÒòÍÃÔÚ¶¯ÂöÖàÑùÓ²»¯Ñо¿ÖеÄÓ¦Óü°Ï£Íû£®Öйú¶¯ÂöÓ²»¯ÔÓÖ¾£¬2003£¬11(4):371-375

2.Fan J,Watanabe T.Transgenic rabbits as therapeutic protein bioreactors and human disease models. Pharmacol Ther, 2003, 99 (3): 261-282

3.Ishibashi S,Brown MS,Goldslein JL,el al. Hyperchol eslerolemia in low density lipoprolein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clio Invest, 1993, 92(2):883-893

4.Kita T, Brown MS, Watanabe Y, el al. Deficiency of low density lipoprotein receptors in li.ver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholeslerolem.ia. Proc Natl Acad Sci USA, 1981, 78 (4):2268-2272

5.Paigen B, Morrow A, Brandon C, el al. Variation in susceptibility lo atherosclerosis among inbred strains of mice. Atherosclerosis, 1985,57 (1):65-73

6.Piedrahita JA,Zhang SH,Hagaman JR,el al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA, 1992,89 (10):4471-4475

7.Plump AS,Smith JD, Hayek T, el al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-de[icient mice created by homologous recombination in ES cells. Cell, 1992, 71 (2):343-353

8.Yu Q,Li Y,WaqarAB,et al. Temporal and quantitative analysis of atherosclerotic lesions in diet-induced hypercholeslerolemic rabbits. J Biomed Biotechnol, 2012, 2012:506159

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿